James Lee

Controller, Former Interim Chief Financial OfficeratNiagen Bioscience· In the 2024 proxy

Pay in FY2024Niagen Bioscience stock +271.0% the same year

James Lee was paid $374.5K in FY2024 (Dec). Niagen Bioscience stock rose 271.0% that year.

Pay$100 in the stock at the end of FY23 → $371

Pay is from the Summary Compensation Table of each Niagen Bioscience proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

NAGE
Niagen BiosciencePublic company · 2 yr
- Controller, Former Interim Chief Financial Officer2024 – Present · 2 yrStock in role +74%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?